Literature DB >> 32504990

Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.

Daniel Aletaha1, Xin Wang2, Sheng Zhong3, Stefan Florentinus4, Kelly Monastiriakos5, Josef S Smolen6.   

Abstract

Entities:  

Year:  2020        PMID： 32504990     DOI： 10.1016/j.semarthrit.2020.03.022

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  3 in total

1.  Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An observational study.

Authors:  Małgorzata Wisłowska
Journal:  Reumatologia       Date:  2022-05-18

Review 2.  Curcumin: Useful add-on for Rheumatic Diseases?

Authors:  Stylianos Tomaras; Gernot Keyßer; Eugen Feist
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

3.  Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis.

Authors:  Serena Bugatti; Ludovico De Stefano; Antonio Manzo; Garifallia Sakellariou; Blerina Xoxi; Carlomaurizio Montecucco
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-22       Impact factor: 5.346
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.